首页> 外国专利> METHOD FOR REDUCING MAMMALIAN ANXIETY LEVEL, METHOD FOR REDUCING ANXIETY LEVEL, USE OF DELTA-OPIOID RECEPTOR ANTAGONISTS NOT PENETRATING THROUGH BRAIN-BLOOD BARRIER FOR PREPARING ANXIOLYTIC AGENTS

METHOD FOR REDUCING MAMMALIAN ANXIETY LEVEL, METHOD FOR REDUCING ANXIETY LEVEL, USE OF DELTA-OPIOID RECEPTOR ANTAGONISTS NOT PENETRATING THROUGH BRAIN-BLOOD BARRIER FOR PREPARING ANXIOLYTIC AGENTS

机译:降低哺乳动物焦虑水平的方法,降低焦虑水平的方法,使用不穿透脑血屏障的Δ-阿片受体拮抗剂来制备抗焦虑药

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: present group of inventions refers to medicine, namely neurology and therapy, and concerns reducing mammalian anxiety level. That is ensured by delta-opioid receptor antagonists not penetrating through brain-blood barrier such as M-154129; ICI 154,129;N,N-Di(2-propenyl)-L-Tyr-N-[2- [[(S)-2-[[(S)-l-carboxy-3-methylbutyl]amino]-2-oxo-l- benzylethyl]thio]ethyl]-Gly-NH2.;EFFECT: provided anxiolytic effect ensured by reciprocity of the peripheral and central endogenic opioid system that causes activation of the delta opioid system in the central nervous system by suppression of peripheral delta-opioid receptors in stomach.;3 cl, 3 ex, 3 tbl
机译:领域:本发明涉及药物,即神经病学和治疗,并且涉及降低哺乳动物的焦虑水平。不通过脑血屏障渗透的δ-阿片受体拮抗剂(例如M-154129)可确保这一点; ICI 154,129; N,N-二(2-丙烯基)-L-Tyr-N- [2-[[(S)-2-[[(S)-1-羧基-3-甲基丁基]氨基] -2-氧--1-苄基乙基]硫基]乙基] -Gly-NH2。作用:通过抑制外周和中枢内源性阿片样物质系统的互作性,提供了抗焦虑作用,该相互作用通过抑制外周δ而引起中枢神经系统中的δ阿片样物质系统的活化。 -阿片受体在胃中。; 3 cl,3 ex,3 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号